COMMUNIQUÉS West-GlobeNewswire

PetMed Express D/B/A 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2018
16/01/2018
DELRAY BEACH, Fla., Jan. 16, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) will announce its financial results for the quarter ended December 31, 2017 on Monday, January 22, 2018 at 8:00 A.M. Eastern [...]
Interface People (IPeople) and Novaseek Research Announce Partnership
16/01/2018
CAMBRIDGE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Interface People (IPeople), a premiere healthcare integration provider and Novaseek Research, Inc., a health IT for life sciences organization, today announced a [...]
Athenex Receives Positive Feedback from FDA on the Design of Phase III Clinical Trial for Oraxol
16/01/2018
BUFFALO, N.Y., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Biotricity Announces the Addition of Artificial Intelligence to its Remote Patient Monitoring Platform
16/01/2018
REDWOOD CITY, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
RedHill Biopharma Announces Final Results from Phase II Study with BEKINDA® for IBS-D
16/01/2018
TEL-AVIV, Israel and RALEIGH, N.C., Jan. 16, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Mitochondrial assay breakthrough announced by Biolog
16/01/2018
HAYWARD, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biolog, Inc. announced today the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial [...]
Transactions in relation to share buyback program
16/01/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Innovation Pharmaceuticals Presents at 2018 Biotech Conference; Oral Mucositis Drug Candidate Garners Exceptional Interest After Successful Phase 2 Trial
16/01/2018
BEVERLY, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders of a productive appearance by [...]
AveXis Announces Proposed Public Offering of Common Stock
16/01/2018
CHICAGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) today announced that it intends to offer and sell, subject to market conditions, up to $400 million of shares of its common stock in an [...]
Saniona AB: Saniona initiates Phase I study with new Tesomet tablet
16/01/2018
PRESS RELEASE January 16, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has dosed the first 10 participants in a Phase 1 pharmacokinetic study of Tesomet using the new [...]
AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy
16/01/2018
– Company to expand study of AVXS-101 into additional SMA populations including pre-symptomatic, older pediatric Type 2 and Type 3 SMA patients – – First patient dosed in Phase 1 trial of AVXS-101 in SMA Type 2 – [...]
FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY
16/01/2018
Company release January 16, 2018 at 2:00 PM EET NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY The shareholders of FIT Biotech Oy are invited to an extraordinary general meeting, which is to be held [...]
Midatech and UCSF receive IND approval for DIPG treatment MTX110
16/01/2018
16 January 2018 Midatech Pharma PLC ("Midatech", "Company" or "Group") Midatech and UCSF receive IND approval for DIPG treatment MTX110 - First treatment in patients in US expected as scheduled in Q1 2018 Midatech [...]
Capricor Announces Licensing of Additional Patent Applications from Cedars-Sinai Medical Center for Cellular and Exosome-based Technologies
16/01/2018
LOS ANGELES, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) announced today that it has added seven new patent applications to its existing Exclusive License Agreements with Cedars-Sinai Medical [...]
Leap Therapeutics Announces First Patient Dosed with TRX518 Combination Therapy in Advanced Solid Tumors Trial
16/01/2018
CAMBRIDGE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that the first patient has been [...]
MPX Appoints New Chief Financial Officer
16/01/2018
TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new Chief Financial [...]
Cambrex & AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility
16/01/2018
EAST RUTHERFORD, N.J., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today held an opening [...]
Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical Hypertension
16/01/2018
NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Exergen Gears Up for Severe Cold and Flu Season
16/01/2018
WATERTOWN, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- As Australia’s flu season predicted earlier this year, North America is beginning to see the effects of a high intense flu season. The main flu strain for 2017-18 is [...]

Pages